Analysis of Metabolic Factors Associated with Hyperuricemia in Diabetes Mellitus

  • Min Zhang Qinghai University
  • Yanming Ren Qinghai University
DOI: https://doi.org/10.18686/aem.v11i4.340
Keywords: Diabetes Mellitus, Hyperuricemia, Metabolic Factors

Abstract

After the occurrence of diabetes in patients, with the increase of the course of disease and the increase of the age of patients, the incidence of other combined diseases in patients is also increasing. Diabetes combined with hyperuricemia is a common clinical disease, and 40% of patients with diabetes will develop hyperuricemia and other complications, which not only makes the treatment of the disease more difficult, but also increases the burden of the hospital. Therefore, to analyze the metabolic factors related to hyperfatemia, and to provide a reference for the clinical exploration of active and effective treatment.

References

[1] Marco Meloni, Valentina Izzo, Erika Vainieri, Laura Giurato, Valeria Ruotolo,Luigi Uccioli.Management of negative pressure wound therapy in the treatment of diabetic foot ulcers[J]. World Journal of Orthopedics: 2015,6(4):387-393.

[2] Liu JC, Tang CY, Lu SY et al., a famous Chinese medicine practitioner in China, discusses the pathogenesis characteristics of adolescent central obesity based on "qi change theory"[J].Journal of Hainan Medical College,2020(8):56-60.

[3] Pan LB, Han P, Ma SR, et al. Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia [J]. Journal of pharmaceutical sciences, 2020,0(2):249-261.

[4] Cappuuio FP, Strazzullo P, Farinaro E, et al. Reduction of serum uric acid by hormonal replacement therapy in postmenopausal with hyperuricemia. Lancet, 1999, 354: 650.

[5] Alderman M, Aiyer KJ. Uric acid: role in cardiovascular disease and effects of losartan. Curr Med Res Opin, 2004,20:369-379.
Published
2023-03-02
Issue
Vol 11, No 4 (2022)
Section
Original Research Article

Copyright (c) 2023 Min Zhang, Yanming Ren

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear

Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.